Therapeutic Potential of Spleen Tyrosine Kinase Inhibition for Treating High-Risk Precursor B Cell Acute Lymphoblastic Leukemia
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
authors
status
publication date
- May 14, 2014
has subject area
- 06 Biological Sciences (FoR)
- 11 Medical and Health Sciences (FoR)
- Administration, Oral (MeSH)
- Adult (MeSH)
- Aminopyridines (MeSH)
- Animals (MeSH)
- Cell Proliferation (MeSH)
- Cell Survival (MeSH)
- Child (MeSH)
- Female (MeSH)
- Humans (MeSH)
- Intracellular Signaling Peptides and Proteins (MeSH)
- Leukemia (MeSH)
- Male (MeSH)
- Mice (MeSH)
- Mice, SCID (MeSH)
- Morpholines (MeSH)
- Mutation (MeSH)
- Neoplasm Transplantation (MeSH)
- Niacinamide (MeSH)
- Oligonucleotide Array Sequence Analysis (MeSH)
- Oxazines (MeSH)
- Phosphorylation (MeSH)
- Precursor Cell Lymphoblastic Leukemia-Lymphoma (MeSH)
- Precursor Cells, B-Lymphoid (MeSH)
- Protein Kinase Inhibitors (MeSH)
- Protein-Tyrosine Kinases (MeSH)
- Pyridines (MeSH)
- Pyrimidines (MeSH)
- Recurrence (MeSH)
- Signal Transduction (MeSH)
- Spleen (MeSH)
- Syk Kinase (MeSH)
- Treatment Outcome (MeSH)
published in
- Science Translational Medicine Journal